Minaris Regenerative Medicine GmbH has 1,024 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 30.4%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
Minaris Regenerative Medicine is a global contract development and manufacturing organization for the production of cell and gene therapy products. We offer our clients clinical and commercial manufacturing services, development solutions, and technologies. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. At Minaris, we are creating cell therapy miracles together. Minaris Regenerative Medicine is wholly owned by the Resonac Group.
As of September 2025
Apceth Biopharma
workforce metrics
Headcount
1k
Avg. Salary
$108.4k
Tenure
2.3yr
Growth Rate
30.4%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of Apceth Biopharma annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of Apceth Biopharma annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?